DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,253 | +2.6% | 37,297 | -0.7% | 0.76% | +9.7% |
Q2 2023 | $9,018 | -11.0% | 37,576 | -6.6% | 0.69% | -14.9% |
Q1 2023 | $10,138 | -8.1% | 40,220 | -3.3% | 0.81% | -11.5% |
Q4 2022 | $11,035 | -99.9% | 41,577 | -2.5% | 0.92% | -6.4% |
Q3 2022 | $11,020,000 | +0.5% | 42,664 | -1.3% | 0.98% | +7.0% |
Q2 2022 | $10,961,000 | -14.0% | 43,234 | -0.5% | 0.92% | +1.0% |
Q1 2022 | $12,743,000 | -13.4% | 43,442 | -2.9% | 0.91% | -5.2% |
Q4 2021 | $14,719,000 | +7.0% | 44,736 | -1.0% | 0.96% | -4.0% |
Q3 2021 | $13,759,000 | +12.0% | 45,193 | -1.3% | 1.00% | +13.8% |
Q2 2021 | $12,282,000 | +16.0% | 45,768 | -1.4% | 0.88% | +10.2% |
Q1 2021 | $10,587,000 | +0.5% | 46,439 | -2.1% | 0.80% | -2.0% |
Q4 2020 | $10,536,000 | +0.2% | 47,431 | -2.9% | 0.81% | -15.0% |
Q3 2020 | $10,518,000 | +19.2% | 48,844 | -2.1% | 0.95% | +11.2% |
Q2 2020 | $8,823,000 | +24.2% | 49,893 | -2.8% | 0.86% | +2.3% |
Q1 2020 | $7,104,000 | -10.6% | 51,326 | -0.9% | 0.84% | +11.0% |
Q4 2019 | $7,949,000 | +3.6% | 51,793 | -2.5% | 0.76% | -5.0% |
Q3 2019 | $7,675,000 | +0.4% | 53,138 | -0.6% | 0.80% | +0.4% |
Q2 2019 | $7,642,000 | +6.9% | 53,471 | -1.2% | 0.79% | +2.7% |
Q1 2019 | $7,146,000 | +25.1% | 54,125 | -2.3% | 0.77% | +8.7% |
Q4 2018 | $5,714,000 | -5.6% | 55,415 | -0.5% | 0.71% | +11.3% |
Q3 2018 | $6,051,000 | +10.8% | 55,685 | +0.6% | 0.64% | +3.2% |
Q2 2018 | $5,461,000 | +0.2% | 55,345 | -0.6% | 0.62% | -0.5% |
Q1 2018 | $5,449,000 | +5.1% | 55,655 | -0.4% | 0.62% | +9.1% |
Q4 2017 | $5,186,000 | +7.2% | 55,870 | -0.9% | 0.57% | +3.5% |
Q3 2017 | $4,838,000 | -2.9% | 56,398 | -4.4% | 0.55% | -6.8% |
Q2 2017 | $4,981,000 | +2.4% | 59,019 | +3.8% | 0.59% | -1.3% |
Q1 2017 | $4,863,000 | +11.1% | 56,856 | +1.1% | 0.60% | +5.1% |
Q4 2016 | $4,377,000 | +0.4% | 56,228 | +1.1% | 0.57% | +0.7% |
Q3 2016 | $4,358,000 | -21.7% | 55,599 | +0.9% | 0.56% | -21.6% |
Q2 2016 | $5,564,000 | +4.8% | 55,094 | -1.6% | 0.72% | +3.1% |
Q1 2016 | $5,309,000 | +0.0% | 55,969 | -2.1% | 0.70% | -3.9% |
Q4 2015 | $5,308,000 | -6.3% | 57,149 | -14.0% | 0.73% | -7.9% |
Q3 2015 | $5,665,000 | -5.0% | 66,479 | -4.6% | 0.79% | +5.2% |
Q2 2015 | $5,963,000 | -0.6% | 69,674 | -1.4% | 0.75% | +0.7% |
Q1 2015 | $5,998,000 | -1.9% | 70,652 | -1.0% | 0.74% | -2.2% |
Q4 2014 | $6,116,000 | +13.2% | 71,357 | +0.4% | 0.76% | +9.6% |
Q3 2014 | $5,402,000 | -3.1% | 71,094 | +0.4% | 0.70% | -1.8% |
Q2 2014 | $5,576,000 | -47.0% | 70,820 | -49.5% | 0.71% | +1.1% |
Q1 2014 | $10,515,000 | +93.1% | 140,195 | +98.7% | 0.70% | -2.6% |
Q4 2013 | $5,446,000 | +12.1% | 70,540 | +0.7% | 0.72% | +4.1% |
Q3 2013 | $4,856,000 | +9.1% | 70,059 | -0.4% | 0.69% | +2.2% |
Q2 2013 | $4,452,000 | – | 70,339 | – | 0.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |